JULIANNE JOHN: Open Payments
NPI 1689292856 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,899 in 48 payments from 10 companies in 2025. Trend: 2023 $636 · 2024 $892 · 2025 $1,899
Food & beverage: $1,787Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $419 |
| Axsome Therapeutics, Inc. | 5 | $401 |
| ABBVIE INC. | 9 | $345 |
| Neurocrine BioSciences, Inc. | 9 | $288 |
| Alkermes, Inc. | 1 | $130 |
| Vanda Pharmaceuticals Inc. | 4 | $105 |
| Janssen Pharmaceuticals, Inc | 4 | $93 |
| Lundbeck LLC | 2 | $52 |
| Tris Pharma Inc | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: Auvelity, VRAYLAR, INGREZZA, AUSTEDO XR, UZEDY, ARISTADA, FANAPT, REXULTI.
Industry payments across WI — which companies pay providers there.
